In this webinar, with Mark Uhlik from OncXerna Therapeutics – discover how the Xerna TME Panel was developed to understand the dominant biology of the tumor microenvironment and align to particular therapeutic modalities. Register Today.

The webinar will cover the following topics:

  • An overview of the RNA-based Xerna TME Panel and its key biological features
  • The development and validation of the Xerna TME Panel
  • Potential clinical and research applications of the Xerna TME Panel to support multiple oncology therapeutics, particularly immune checkpoint inhibitors and anti-angiogenic agents, across a variety of tumor types
  • Future development of the Xerna TME Panel as an RUO and CDx assay

Featured Speaker

Mark Uhlik

Vice President, Head of Research and Biomarker Discovery
OncXerna Therapeutics

Mark is a seasoned leader in translational oncology and drug discovery/development with over 15 years of experience in the pharmaceutical industry. Mark earned his B.S. in Microbiology from Colorado State University and his Ph.D. in Microbiology and Immunology at Pennsylvania State University College of Medicine. He performed post-doctoral work at University of Colorado Health Sciences Center and at University of North Carolina School of Medicine. Mark has authored over 35 peer-reviewed publications in addition to book chapters and patents.

Date:  Wednesday, October 27, 2021
Time:  11am ET / 8am PT
Duration:  1 Hour

Register now for this webinar